Medical Devices & Tech

Asuragen, Inc.

2150 Woodward St., Suite 100
Austin, TX 78744 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Fully integrated RNA-based therapeutic and diagnostics company with a focus on microRNA

Management Matt Winkler, Ph.D., Chairman of the Board and CSO; Matthew McManus, M.D., Ph.D., President and CEO; Lynne Hohlfeld, Sr. VP, Chief Financial Officer; Ana C. Ward, Esq., M.S., M.B.A., Sr. VP, General Counsel; Darin Leigh, Sr. VP, Commercial Operations; Bernard F. Andruss, Ph.D., VP, Diagnostic Development & Regulatory Affairs; Gary J. Latham, Ph.D., VP, Research and Technology Development; Eric Lindquist, M.B.A., CLSp(CG), VP, Business Development Companion Diagnostics

Click here for Financial Data
Keywords: advamed, Diagnostics, molecular, miRNA, management, PatientMonitoring


Updated: Oct. 22, 2015


Asuragen is a molecular diagnostics company with a pioneering position in miRNA using genomics to drive better patient management through best-in-class clinical testing solutions. The company uses a b......view more

Products / Services

Our diagnostic product portfolio consists of multiplex oncology assays, novel RT-qPCR leukemia products, innovative PCR assays for Fragile-X testing, RNA stabilization technologies, and industry-leadi......view more

Technology / Differentiation

Asuragen is empowered with a high level of scientific expertise and assay development capabilities, CLIA and GLP testing services, and an established cGMP manufacturing facility, which allow it to spa...view more